全球兽医诊断市场规模、份额、成长分析、按产品、按动物、按技术 - 产业预测 2023-2030

2022年全球兽医诊断市场规模将为73亿美元，从2023年的81亿美元成长到2031年的190亿美元，复合年增长率预计将成长11.2%。

近年来，由于动物疾病的流行以及对准确、及时的诊断工具的需求不断增加，全球兽医诊断市场经历了显着增长。特别是在新兴国家，宠物主人数量迅速增加，为兽医诊断市场的扩张做出了巨大贡献。此外，人们对兽医领域的预防性保健越来越感兴趣，对早期发现疾病的诊断测试的需求也在增加。伴同性动物医疗保健的显着增长是宠物饲主越来越愿意投资诊断服务以确保其动物的健康。从地区来看，北美和欧洲是兽医诊断的重要市场，受益于较高的宠物医疗保健意识和完善的兽医基础设施。然而，亚太和拉丁美洲的新兴经济体提供了充满希望的成长机会。这些地区可支配收入的增加和对动物健康意识的提高正在推动兽医诊断市场的成长。因此，该行业的公司越来越注重扩大在亚太和拉丁美洲的业务，以利用这些快速成长的市场。总体而言，在宠物饲养、预防性医疗保健和扩大地理覆盖范围等不断变化的趋势的推动下，全球兽医诊断市场预计将继续其成长轨迹。

目录

执行摘要

• 市场概况
• 命运之轮

调查方法

• 资讯采购
• 次要/一级资讯来源
• 市场规模估算
• 市场假设与限制

母市场分析

• 市场概况
• 市场规模
• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务

主要市场考察

• 技术分析
• 价格分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 智慧财产权分析
• 贸易分析
• Start-Ups分析
• 原料分析
• 创新矩阵
• 研发线产品分析
• 总体经济指标
• 主要投资分析
• 关键成功因素
• 竞争程度

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 监管形势
• 波特的分析
• 对未来中断的特殊考虑

全球兽医诊断市场：按产品

• 市场概况
• 免疫诊断测试
• 分子诊断测试
• 临床化学
• 血液分析仪
• 诊断影像

全球兽医诊断市场：依动物分类

• 市场概况
• 家畜
• 伴同性动物

全球兽医诊断市场：依技术分类

• 市场概况
• PCR（聚合酵素链锁反应）
• ELISA（酵素结合免疫吸附检测法）
• 微阵列
• 免疫检测
• 影像诊断技术（X光）
• MRI
• 超音波
• 其他的

按地区分類的全球兽医诊断市场规模

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争形势

• 前5名企业对比
• 主要企业市场定位（2021年）
• 主要市场参与者所采取的策略
• 关键成功策略
• 近期市集活动
• 主要企业市场占有率（2021年）

主要企业简介

• IDEXX Laboratories, Inc.
• Zoetis, Inc.
• Thermo Fisher Scientific Inc.
• BioMerieux SA
• Virbac Corporation
• Heska Corporation
• Abaxis, Inc.
• NEOGEN Corporation
• Randox Laboratories Ltd.
• Bio-Rad Laboratories, Inc.
• Beckman Coulter, Inc.
• Abbott Laboratories
• Roche Diagnostics
• Siemens Healthcare
• Danaher Corporation
• Johnson & Johnson
• Pfizer
• Merck Animal Health
• Boehringer Ingelheim Animal Health
• Elanco Animal Health

Global Veterinary Diagnostics Market size was valued at USD 7.3 billion in 2022 and is poised to grow from USD 8.1 billion in 2023 to USD 19.0 billion by 2031, growing at a CAGR of 11.2% during the forecast period (2024-2031).

The global Veterinary Diagnostics market has observed a substantial growth recently, driven by the increasing prevalence of animal diseases and the consequent demand for accurate and timely diagnostic tools. Developed countries, in particular, have seen a surge in pet ownership, contributing significantly to the expansion of the veterinary diagnostics market. Furthermore, there is a growing attention on preventive healthcare in the veterinary field, leading to a rising demand for diagnostic tests aimed at early disease detection. A notable surge in companion animal healthcare is the growing willingness of pet owners to invest in diagnostic services to ensure the well-being of their animals. Geographically, North America and Europe have been prominent markets for veterinary diagnostics, benefiting from a high level of awareness about pet healthcare and well-established veterinary infrastructure. However, emerging economies in Asia-Pacific and Latin America are now presenting promising growth opportunities. Rising disposable incomes and increasing awareness of animal health in these regions are driving the growth of the veterinary diagnostics market. As a result, companies operating in this sector are increasingly focusing on expanding their presence in Asia-Pacific and Latin America to capitalize on these burgeoning markets. Overall, the global veterinary diagnostics market is expected to continue its growth trajectory, propelled by evolving trends in pet ownership, preventive healthcare, and expanding geographical reach.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Diagnostics Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary Diagnostics Market Segmental Analysis

The global veterinary diagnostics market is segmented on the basis of product, animal, technology, and region. By product type, the market is segmented into immunodiagnostic tests, molecular diagnostic tests, clinical chemistry, hematology analyzers, and diagnostic imaging. By animal type, the market is segmented into livestock, companion animals. By technology, the market is segmented into, PCR (Polymerase Chain Reaction), ELISA (Enzyme-Linked Immunosorbent Assay), microarrays, immunoassay, diagnostic imaging technologies (X-ray, MRI, Ultrasound), and others. By region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.

Drivers of the Global Veterinary Diagnostics Market

The increase in widespread presence of animal diseases emphasizes the need for precise and timely diagnostic tools to ensure prompt treatment and effective disease management. Furthermore, the rise in pet ownership, mainly in developed regions, is a significant driver of market growth because pet owners are increasingly seeking advanced healthcare solutions for their animal companions. Technological advancements in diagnostic tools, including molecular diagnostic tests and advanced imaging techniques, are playing an important role in maintaining the accuracy and efficiency of veterinary diagnostics. These innovations contribute to improved disease detection and treatment outcomes, thus benefiting both animals and their owners.

Restraints in the Global Veterinary Diagnostics Market

The main problem for the veterinary diagnostics market is the high cost of advanced methods and equipment. Buying and running these tools is expensive, especially for clinics and labs in places with little money. Also, there's a challenge because rules about these tools are different in each country. These different rules can make it hard to bring new diagnostic technologies into some places.

Market Trends of the Global Veterinary Diagnostics Market

There's a trend in veterinary diagnostics where high-tech stuff like artificial intelligence and machine learning are getting used more. These technologies help make diagnosing diseases in animals faster and more accurate. Another trend is that vets are using point-of-care diagnostics, where they can do tests right where the animal is being treated. This makes it faster to make decisions and start treatment. Also, telemedicine in veterinary care is becoming more common, where vets can do consultations remotely using digital platforms and share diagnostic information online.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Veterinary Diagnostics Market by Product

• Market Overview
• Immunodiagnostic Tests
• Molecular Diagnostic Tests
• Clinical Chemistry
• Hematology Analyzers
• Diagnostic Imaging

Global Veterinary Diagnostics Market by Animal

• Market Overview
• Livestock
• Companion Animals

Global Veterinary Diagnostics Market by Technology

• Market Overview
• PCR (Polymerase Chain Reaction)
• ELISA (Enzyme-Linked Immunosorbent Assay)
• Microarrays
• Immunoassay
• Diagnostic Imaging Technologies (X-ray
• MRI
• Ultrasound)
• and Others

Global Veterinary Diagnostics Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• IDEXX Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Heska Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abaxis, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NEOGEN Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments